Background:Scale-up of antiretroviral therapy (ART) and introduction of treat-all strategy necessitates population-level monitoring of acquired HIV drug resistance (ADR) and pretreatment drug resistance (PDR) mutations.Methods:Blood samples were collected from 4973 HIV-positive individuals residing in 30 communities across Botswana who participated in the Botswana Combination Prevention Project (BCPP) in 2013\u20132018. HIV sequences were obtained by long-range HIV genotyping. Major drug-resistance mutations (DRMs) and surveillance drug resistance mutations (SDRMs) associated with nucleoside reverse transcriptase inhibitors (NRTI) and nonnucleoside reverse transcriptase inhibitors (NNRTI) were analyzed according to the Stanford University H...
Background: Drug resistance testing before initiation of, or during, antiretroviral therapy (ART) i...
In 2004, Malawi began scaling up its national antiretroviral therapy (ART) program. Because of limit...
HIV care programs in resource-limited settings have hitherto concentrated on antiretroviral therapy ...
As more human immunodeficiency virus (HIV)-infected patients access combination antiretroviral thera...
As more human immunodeficiency virus (HIV)–infected patients access combination antiretroviral thera...
OBJECTIVE To estimate the prevalence of NRTI and NNRTI drug resistance mutations in patients fail...
INTRODUCTION: The rise of HIV-1 drug resistance to non-nucleoside reverse-transcriptase inhibitors (...
HIV drug resistance (HIVDR) is of increasing health concern, especially among key populations. We in...
Introduction The rise of HIV-1 drug resistance to non-nucleoside reverse-transcript...
OBJECTIVE To estimate the prevalence of NRTI and NNRTI drug resistance mutations in patients fail...
CITATION: Steegen, K. et al. 2016. Moderate levels of pre-treatment HIV-1 antiretroviral drug resist...
Following the World Health Organization (WHO)’s 3 by 5 initiative, antiretroviral treatment (ART) ...
Introduction: Antiretroviral therapy plays a major role in reducing the impact of Human Immunodefici...
BackgroundThere is concern over increasing prevalence of non-nucleoside reverse-transcriptase inhibi...
BACKGROUND: Drug resistance testing before initiation of, or during, antiretroviral therapy (ART) is...
Background: Drug resistance testing before initiation of, or during, antiretroviral therapy (ART) i...
In 2004, Malawi began scaling up its national antiretroviral therapy (ART) program. Because of limit...
HIV care programs in resource-limited settings have hitherto concentrated on antiretroviral therapy ...
As more human immunodeficiency virus (HIV)-infected patients access combination antiretroviral thera...
As more human immunodeficiency virus (HIV)–infected patients access combination antiretroviral thera...
OBJECTIVE To estimate the prevalence of NRTI and NNRTI drug resistance mutations in patients fail...
INTRODUCTION: The rise of HIV-1 drug resistance to non-nucleoside reverse-transcriptase inhibitors (...
HIV drug resistance (HIVDR) is of increasing health concern, especially among key populations. We in...
Introduction The rise of HIV-1 drug resistance to non-nucleoside reverse-transcript...
OBJECTIVE To estimate the prevalence of NRTI and NNRTI drug resistance mutations in patients fail...
CITATION: Steegen, K. et al. 2016. Moderate levels of pre-treatment HIV-1 antiretroviral drug resist...
Following the World Health Organization (WHO)’s 3 by 5 initiative, antiretroviral treatment (ART) ...
Introduction: Antiretroviral therapy plays a major role in reducing the impact of Human Immunodefici...
BackgroundThere is concern over increasing prevalence of non-nucleoside reverse-transcriptase inhibi...
BACKGROUND: Drug resistance testing before initiation of, or during, antiretroviral therapy (ART) is...
Background: Drug resistance testing before initiation of, or during, antiretroviral therapy (ART) i...
In 2004, Malawi began scaling up its national antiretroviral therapy (ART) program. Because of limit...
HIV care programs in resource-limited settings have hitherto concentrated on antiretroviral therapy ...